RxDoctor Payments Data

Aimee Ledesma, MD

Family Medicine · Pleasant Prairie, WINPI 1033166970

Payments from drug & device makers

$2,671in general payments, 2019–2025

Across 153 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$597
  • Johnson & Johnson$258
  • AstraZeneca$220
  • Pfizer$206
  • AbbVie$175
  • Lilly USA, LLC$151
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,671 in reported general payments places this provider in the 90th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$76,208
Medicare patients
203
Services billed
737

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban72$54,178
XareltoRivaroxaban46$34,316
JanuviaSitagliptin Phosphate33$28,165
TrulicityDulaglutide16$22,577
MounjaroTirzepatide13$17,782
OzempicSemaglutide11$12,455
VyvanseLisdexamfetamine Dimesylate11$7,485
Lisdexamfetamine Dimesylate21$5,554
Fluticasone-SalmeterolFluticasone Propion/Salmeterol41$4,753
Levothyroxine Sodium295$3,519
Novolog FlexpenInsulin Aspart13$3,253
Ezetimibe144$3,191
SynthroidLevothyroxine Sodium50$2,709
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,483
Atorvastatin Calcium248$2,185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$206$54,17872 claims
Lilly USA, LLCTrulicity, Mounjaro$151$40,35929 claims
Johnson & JohnsonXarelto$258$34,31646 claims
Novo NordiskOzempic$597$12,45511 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$26$7,48511 claims
AbbVieSynthroid$175$2,70950 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Pleasant Prairie

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →